• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[终末期肾功能不全患者的贫血:慢性透析患者的铁动力学、红细胞存活时间及红细胞酶]

[Anemia in terminal kidney insufficiency: ferrokinetics, erythrocyte survival times and erythrocyte enzymes in chronic dialysis patients].

作者信息

Junkers K, Jontofsohn R, Meuret G, Blume K G, Heinze V

出版信息

Nucl Med (Stuttg). 1975 Dec 15;14(4):355-64.

PMID:1215213
Abstract

Radio-iron utilization was nearly normal in these patients, only bilateral nephrectomized patients showed a reduced radio-iron utilization. Red blood half-life span was shortened in all patients, well corresponding to the degree of anemia. Parameters of erythropoesis like plasma iron clearance, bone marrow transit time, erythron iron turnover, non erythron iron turnover and hemolysis iron turnover failed to quantitate disorders of red blood cell regeneration in these patients. No defect in red blood cell enzyme activity could be demonstrated. Enzymes of glycolysis were increased corresponding to the reduced erythrocyte half-life span.

摘要

这些患者的放射性铁利用率几乎正常,只有双侧肾切除的患者放射性铁利用率降低。所有患者的红细胞半衰期均缩短,与贫血程度密切相关。红细胞生成参数如血浆铁清除率、骨髓转运时间、红细胞铁周转率、非红细胞铁周转率和溶血铁周转率未能定量这些患者红细胞再生的紊乱情况。未发现红细胞酶活性有缺陷。糖酵解酶相应增加,与红细胞半衰期缩短一致。

相似文献

1
[Anemia in terminal kidney insufficiency: ferrokinetics, erythrocyte survival times and erythrocyte enzymes in chronic dialysis patients].[终末期肾功能不全患者的贫血:慢性透析患者的铁动力学、红细胞存活时间及红细胞酶]
Nucl Med (Stuttg). 1975 Dec 15;14(4):355-64.
2
Iron turnover in patients with chronic uraemia treated with hemodialysis.接受血液透析治疗的慢性尿毒症患者的铁周转情况。
Acta Med Acad Sci Hung. 1982;39(3-4):193-200.
3
Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements.通过可溶性转铁蛋白受体水平和铁动力学测量评估血液透析治疗期间的红细胞生成活性。
Am J Kidney Dis. 2001 Mar;37(3):550-6.
4
Erythropoiesis in the anaemia of chronic renal failure: the response to CAPD.
Nephrol Dial Transplant. 1986;1(3):170-4.
5
[Anemia in chronic renal insufficiency].[慢性肾功能不全中的贫血]
Minerva Med. 1978 Nov 10;69(54):3719-23.
6
[Studies of erythrocyte kinetics in idiopathic treatment-resistant anemia using iron 59 and chromium 51].[使用铁59和铬51对特发性难治性贫血患者红细胞动力学的研究]
Nucl Med (Stuttg). 1963;2:Suppl 1:129-34.
7
Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure.重组人促红细胞生成素治疗慢性肾衰竭相关性贫血后的铁平衡
Int J Hematol. 1991 Jun;54(3):195-200.
8
Ferrokinetics: a biologic model for plasma iron exchange in man.铁动力学:人体血浆铁交换的生物学模型。
J Clin Invest. 1970 Feb;49(2):197-205. doi: 10.1172/JCI106228.
9
Erythropoiesis.红细胞生成
N Engl J Med. 1971 Jul 8;285(2):99-101. doi: 10.1056/NEJM197107082850206.
10
Peculiarities of erythropoiesis in patients with chronic renal failure.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1982;109(5):777-86.